Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04055493
Title Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC (ADAPTcycle)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors West German Study Group

Her2-receptor negative breast cancer



Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Klinikum der Universität München Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum Not yet recruiting Munich Bavaria 80337 Germany Details
Universitätsklinikum Aachen, Frauenklinik - Senologie Recruiting Aachen NRW 52074 Germany Details
Kliniken Essen-Mitte, Klinik für Senologie/Interdisziplinäres Brustzentrum Recruiting Essen NRW 45136 Germany Details
Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda Recruiting Moenchengladbach NRW 41061 Germany Details
*Shaded cells indicate that there was no data available from for the field